Clinical trial
Association Between Modifiable Risk Factors and Cognitive Function in Patients With Coronary Heart Disease
NCT07657624 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Association Between Modifiable Risk Factors and Cognitive Function in Patients With Coronary Heart Disease
- Lead sponsor
- Beijing Anzhen Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 30, 2025
- Completion date
- May 1, 2031
- Enrollment
- 2,352 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cognitive impairment, mild, coronary heart disease